Last Updated: September 28 2022

Ornithine, arginine, and citrulline are the three amino acids involved in the urea cycle. Your body uses ornithine to make polyamines (which play a role in cell growth and proliferation) and the amino acid proline (used to make collagen). Preliminary evidence suggests that ornithine supplementation can improve athletic performance by reducing elevated levels of ammonia.

Ornithine is most often used for


L-Ornithine is a nonprotein amino acid (not used to create proteins) that is an intermediate of the urea cycle, and provision of ornithine to a cell is actually the rate limiting step of the cycle. Ornithine binds with a molecule known as carbamoyl phosphate which requires ammonia to be produced and then is converted into L-Citrulline giving off urea as a byproduct. Due to this, the conversion is one that reduces ammonia concentrations in the blood and concomitantly increases urea.

L-Ornithine is thought to be important for conditions that are characterized by an excess level of ammonia, and this is mainly focused on either hepatic encephalopathy (clinical liver condition) or prolonged cardiovascular exercise. A reduction in serum ammonia has been repeatedly found in persons with hepatic encephalopathy (most studies use infusions, although it appears to apply to high dose oral supplements as well) while there are only two studies assessing exercise; the one that was better suited to assess the influence of ammonia (using prolonged exercise rather than acute exercise) did find an anti-fatigue effect.

Furthermore, reductions in self-reported fatigue have been noted in persons with hepatic encephalopathy and in persons subject to a hangover (the process of getting drunk off of alcohol will increase serum ammonia) when ornithine is taken before drinking, but only in persons sensitive to alcohol perhaps.

There is currently one study using ornithine paired with arginine that noted improvements in lean mass and power output in weightlifters, but this is an old study that has not been replicated and its practical relevance is uncertain.

Finally, the increases in growth hormone seen with ornithine are similar to those seen with arginine. Technically they exist, but as they are very short lived and the body seems to compensate the overall increaes in whole-day growth hormone are not significant. Since the main properties of growth hormone being concerned with (increased lean mass gain and fat loss) are more related to day-long exposure rather than short-bursts, it is unlikely that ornithine has a role here.

In the end, ornithine looks somewhat promising for reducing ammonia concentrations in the blood and thus enhancing performance of prolonged exercise (45 minutes or more) which is in part due to it being elevated in the blood for a few hours after ingestion despite exercise.

What else is Ornithine known as?
Note that Ornithine is also known as:
  • L-Ornithine
Dosage information

Ornithine supplementation (as hydrochloride) is taken in the range of 2-6g daily. Most studies use a dose in this range, but despite serum levels being somewhat dose dependent there is a chance of intestinal distress at doses above 10g.

Most studies use Ornithine hydrochloride (Ornithine HCl) which appears to be effective. Ornithine HCl is 78% Ornithine by weight, and so for the 2-6g range an equivalent dose for L-Ornithine L-Aspartate (50% Ornithine) would be 3.12-9.36g and an equivalent dose for L-Ornithine α-ketoglutarate (47% Ornithine) would be 3.3-10g. These two forms are theoretically more effective, but lack sufficient comparative testing.

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Ornithine
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

4.^Brusilow SW, Maestri NEUrea cycle disorders: diagnosis, pathophysiology, and therapyAdv Pediatr.(1996)
6.^Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici CSuggested guidelines for the diagnosis and management of urea cycle disordersOrphanet J Rare Dis.(2012 May 29)
7.^Choi DE, Lee KW, Shin YT, Na KRHyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiencyJ Korean Med Sci.(2012 May)
8.^Tuchman M, Jaleel N, Morizono H, Sheehy L, Lynch MGMutations and polymorphisms in the human ornithine transcarbamylase geneHum Mutat.(2002 Feb)
9.^Applegarth DA, Toone JR, Lowry RBIncidence of inborn errors of metabolism in British Columbia, 1969-1996Pediatrics.(2000 Jan)
11.^Wallace HMThe physiological role of the polyaminesEur J Clin Invest.(2000 Jan)
12.^Wallace HM, Fraser AV, Hughes AA perspective of polyamine metabolismBiochem J.(2003 Nov 15)
17.^Cynober L, Coudray-Lucas C, de Bandt JP, Guéchot J, Aussel C, Salvucci M, Giboudeau JAction of ornithine alpha-ketoglutarate, ornithine hydrochloride, and calcium alpha-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjectsJ Am Coll Nutr.(1990 Feb)
18.^MacLean DA, Spriet LL, Hultman E, Graham TEPlasma and muscle amino acid and ammonia responses during prolonged exercise in humansJ Appl Physiol.(1991 May)
20.^Mutch BJ, Banister EWAmmonia metabolism in exercise and fatigue: a reviewMed Sci Sports Exerc.(1983)
21.^Nybo L, Dalsgaard MK, Steensberg A, Møller K, Secher NHCerebral ammonia uptake and accumulation during prolonged exercise in humansJ Physiol.(2005 Feb 15)
22.^Graham TE, MacLean DAAmmonia and amino acid metabolism in human skeletal muscle during exerciseCan J Physiol Pharmacol.(1992 Jan)
24.^Elam RP, Hardin DH, Sutton RA, Hagen LEffects of arginine and ornithine on strength, lean body mass and urinary hydroxyproline in adult malesJ Sports Med Phys Fitness.(1989 Mar)
27.^Raabe WSynaptic transmission in ammonia intoxicationNeurochem Pathol.(1987 Feb-Apr)
29.^Morgan MH, Read AE, Speller DCTreatment of hepatic encephalopathy with metronidazoleGut.(1982 Jan)
31.^Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch STherapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind studyHepatology.(1997 Jun)
32.^Ahmad I, Khan AA, Alam A, Dilshad A, Butt AK, Shafqat F, Malik K, Sarwar SL-ornithine-L-aspartate infusion efficacy in hepatic encephalopathyJ Coll Physicians Surg Pak.(2008 Nov)
33.^Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Görtelmeyer R, Hendricks R, Heuser A, Karoff C, Malfertheiner P, Mayer D, Rösch W, Steffens JOral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind studyJ Hepatol.(1998 May)
34.^Soárez PC, Oliveira AC, Padovan J, Parise ER, Ferraz MBA critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatmentArq Gastroenterol.(2009 Jul-Sep)
36.^Jiang Q, Jiang XH, Zheng MH, Chen YPL-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysisJ Gastroenterol Hepatol.(2009 Jan)
37.^Evain-Brion D, Donnadieu M, Roger M, Job JCSimultaneous study of somatotrophic and corticotrophic pituitary secretions during ornithine infusion testClin Endocrinol (Oxf).(1982 Aug)
42.^Morowitz H, Peterson E, Chang SThe synthesis of glutamic acid in the absence of enzymes: implications for biogenesisOrig Life Evol Biosph.(1995 Aug)
43.^Maughan Q, Miller SLDoes formate reduce alpha-ketoglutarate and ammonia to glutamateOrig Life Evol Biosph.(1999 Aug)
44.^Saavedra-Molina A, Piña EOrnithine uptake by rat liver mitochondria: effect of calcium and arginineBiochem Int.(1987 Jul)
46.^Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SKEfficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled studyGastroenterology.(2009 Jun)
50.^Rejniuk VL, Schafer TV, Ivnitsky JJAmmonia potentiates the lethal effect of ethanol on ratsBull Exp Biol Med.(2008 Jun)
52.^Maier KP, Volk B, Hoppe-Seyler G, Gerok WUrea-cycle enzymes in normal liver and in patients with alcoholic hepatitisEur J Clin Invest.(1974 Jun)
53.^Goedde HW, Harada S, Agarwal DPRacial differences in alcohol sensitivity: a new hypothesisHum Genet.(1979 Oct 2)
55.^Le Bricon T, Coudray-Lucas C, Lioret N, Lim SK, Plassart F, Schlegel L, De Bandt JP, Saizy R, Giboudeau J, Cynober LOrnithine alpha-ketoglutarate metabolism after enteral administration in burn patients: bolus compared with continuous infusionAm J Clin Nutr.(1997 Feb)
56.^Kirk SJ, Hurson M, Regan MC, Holt DR, Wasserkrug HL, Barbul AArginine stimulates wound healing and immune function in elderly human beingsSurgery.(1993 Aug)
57.^Kudsk KA, Minard G, Croce MA, Brown RO, Lowrey TS, Pritchard FE, Dickerson RN, Fabian TCA randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complicationsAnn Surg.(1996 Oct)
58.^Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, Antin JH, et alClinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled studyAnn Intern Med.(1992 May 15)
59.^Hall JC, Heel K, McCauley RGlutamineBr J Surg.(1996 Mar)
60.^Donati L, Ziegler F, Pongelli G, Signorini MSNutritional and clinical efficacy of ornithine alpha-ketoglutarate in severe burn patientsClin Nutr.(1999 Oct)
62.^Cynober LAThe use of alpha-ketoglutarate salts in clinical nutrition and metabolic careCurr Opin Clin Nutr Metab Care.(1999 Jan)